跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32 条关于
“MEPSGEN”
全部
32
临床试验
11
药物
7
机构
5
资讯
9
去年
MEPSGEN Launches NanoCalibur™ in US: Advanced Microfluidic Platform for Scalable Nanoparticle Production
去年
PepGen's Clinical Programs Advance for DMD and DM1 Amidst Financial Scrutiny
去年
PepGen Reports Promising Splicing Correction Results in DM1 Clinical Trial
11个月前
PepGen Raises $115 Million to Advance Oligonucleotide Therapies for Neuromuscular Diseases
27天前
Charles River and Medigen Vaccine Biologics Partner to Advance Next-Generation Multivalent Enterovirus Vaccine
10个月前
PepGen Secures U.S. Patent for PGN-EDODM1, Advancing Myotonic Dystrophy Type 1 Treatment
去年
PepGen's PGN-EDO51 Shows Promise in Duchenne Muscular Dystrophy Trial
去年
Memgen Initiates Phase 1 Combination Trial of MEM-288 Plus Docetaxel for Advanced NSCLC
去年
FDA Halts PepGen's DMD Trial, Sanofi's MS Drug Tolebrutinib Gains Breakthrough Status, and Sevasemten Shows Promise in Becker Muscular Dystrophy